Valuation

LIFEPharmsynthez

StockMoscow ExchangeRussiaHealth care

+5.1% today · −40.7% over a year

No score: too little data.

Quality, Trend, Stability: among the weakest. No dividend.

Ratios vs sector

Medians of Health care companies worldwide (too few in the region).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.
Metric	LIFE	Sector median	vs median
P/E	—	28.3 · n=183	—
P/B	—	3.7 · n=351	—
P/S	—	4.1 · n=339	—
EV/EBIT	—	24.6 · n=173	—
Free-cash-flow yield	—	1.6% · n=328	—
Dividend yield	0.00%	0.00% · n=469	—
Return on equity	—	−1.2% · n=361	—
Return on invested capital	—	3.1% · n=326	—
Gross margin	—	64.2% · n=243	—
Net debt / EBITDA	—	1.30 · n=174	—

The largest companies of the same sector and region.


LLYEli Lilly & Co	46.2	31.6	—	1.5%	0.6%	6/10
JNJJohnson & Johnson	41.3	8.2	—	3.1%	1.9%	8/10
ABBVAbbVie	50.0	—	27.6	3.7%	2.9%	6/10
MRKMerck	147.5	8.1	—	4.1%	2.3%	8/10
UNHUnitedHealth	22.2	3.4	16.9	6.5%	2.3%	10/10
NVSNovartis AG	22.2	6.7	18.6	5.7%	2.4%	10/10
NOVNNovartis AG	22.2	6.7	18.6	5.7%	2.8%	10/10
AZNAstraZeneca plc	28.3	5.9	22.8	4.1%	1.7%	6/10
AZNAstraZeneca PLC	28.3	5.9	22.8	4.1%	1.2%	6/10
TMOThermo Fisher Scientific	36.4	4.7	34.5	3.0%	0.3%	9/10

ratios computed by AI-Stock Invest from public filings and end-of-day prices

Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.